Price Targets Show These 3 Stocks Near the $1 Trillion Mark

Key Points

• The $1 trillion club is exclusive—and Tesla, Broadcom, and Eli Lilly are knocking at the door.
• Analyst targets suggest Tesla and Broadcom could reclaim the mark in the next year.
• Eli Lilly remains a standout in the pharmaceuticals sector but may need more runway to reach $1 trillion.

Currently, just eight vaunted stocks boast market capitalizations of over $1 trillion. This includes six of the Magnificent Seven stocks, as well as Warren Buffett's Berkshire Hathaway NYSE: BRK.A. The only non-U.S. stock among these eight is the Saudi Arabian Oil Company, also known as Saudi Aramco. Although technically publicly traded, in practice, the vast majority of investors cannot buy shares directly.

Three other big-name U.S. stocks, in particular, have found themselves flirting with the $1 trillion valuation mark in their history. Below, I’ll detail each of these three names, as well as what analyst price targets say about their ability to reach the $1 trillion mark. However, investors should remain aware that analyst price targets are but one tool to quantify the potential of a stock.

Changes in circumstances for a particular stock or the whole market can cause the assumptions embedded in these price targets to change substantially. Investors should not take them as gospel. All market capitalization, return, and other figures use data as of the Mar. 24 close unless otherwise indicated.

Can Tesla Regain Its Place on the $1 Trillion Mantle? Price Targets Say Yes

The first is Elon Musk’s Tesla NASDAQ: TSLA. The company is notably the only Magnificent Seven stock not to have a $1 trillion or greater valuation. However, Tesla has had multiple bouts of reaching and exceeding this mark. The first came in Oct. 2021. Tesla’s valuation fluctuated above and below $1 trillion for some time until ultimately falling below this threshold in Apr. 2022. It would not return above it for over two years. In mid-November 2024, the company eclipsed the $1 trillion mark again. Tesla eventually reached its highest valuation of all time on Dec. 17 of over $1.5 trillion.

However, since then, it has been a ride almost straight down for the stock. Tesla is now down 43% from this all-time high. Through the generalized tech selloff in 2025, Tesla’s drop has been particularly pronounced. Its 32% drop year-to-date is over double the fall of the next worst-performing Mag 7 stock, Apple NASDAQ: AAPL. Tesla’s market cap is now around $895 billion. 

Remove Ads

Thus, the stock would need to rise around 12% to once again reach a $1 trillion valuation. MarketBeat has tracked 14 analysts' price target updates on Tesla in March. The average upside implied by these price targets is 22%. This indicates that many analysts believe Tesla can regain its place on the $1 trillion mantle in the next 12 months.

Analysts Indicate Broadcom May Have More Than Enough in the Tank to Reach $1 Trillion

Next up is the semiconductor giant Broadcom NASDAQ: AVGO. Broadcom briefly achieved the $1 trillion mark, closing above that level first on Dec. 13, 2024. The company reached its all-time high valuation of nearly $1.17 trillion on the next trading day. Broadcom stock ultimately closed below that level on Feb. 24, with a bit of fluctuation above and below it through that two-and-a-half-month period.

However, Broadcom is down around 12% from the last time it held a $1 trillion valuation, now with a market cap of $900 billion. Broadcom needs to rise around 11% to achieve that valuation again. MarketBeat tracked seven analyst price target updates on Broadcom since the firm’s latest earnings release on Mar. 6.

The average of these price targets implies an upside of 39% in Broadcom shares. This shows several analysts are bullish on Broadcom’s ability to achieve a $1 trillion or greater valuation.

Eli Lilly May Have to Wait a Little Longer to Join the $1Trillion Club

Last is the world's largest pharmaceutical company, Eli Lilly NYSE: LLY. Lilly has achieved this title through a massive 205% increase in its share price over the past three years. The firm’s success comes from its strong weight loss and diabetes products. Its impressive operational execution in this area has also played a key role.

Eli Lilly is the only name on this list that has not reached a $1 trillion valuation before. The stock reached its all-time high closing valuation of $864 billion on Aug. 30, 2024.

Lilly’s valuation now sits at $778 billion, necessitating a rise of around 29% to reach $1 trillion. MarketBeat tracked six analysts who updated past or set initial price targets on Lilly shares in 2025. The average of these analysts' price targets implies a 23% upside in Lilly shares. If Lilly achieved this amount of upside, its market capitalization would reach around $956 billion, falling moderately short of the $1 trillion mark.